Arca
Skip to content
Tools
Tools

SERPINC1: Antithrombin-III

A drug works by acting on something in the body, usually a protein made by one gene. This is a page for each of those targets: the drugs that hit it and the diseases it is tied to.

Most important serine protease inhibitor in plasma that regulates the blood coagulation cascade.

  • Drugs that act on it: 13
  • Approved: 10
  • In phases 1 to 3: 3
  • Sponsors: 9

Who Is On It, and How Far Along

Every drug ChEMBL records acting on SERPINC1, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Other

Approved10

  • Heparin
  • Heparin sodium
  • Heparin calcium
  • Enoxaparin sodium
  • Dalteparin sodium
  • Tinzaparin sodium
  • Fondaparinux
  • Nadroparin calcium
  • Ardeparin sodium
  • Danaparoid sodium

Phase 33

  • Bemiparin sodium
  • Parnaparin sodium
  • Semuloparin sodium

Phase 20

    Phase 10

      Sponsors

      Drugs on this target per company: the US application holder, else the industry sponsor leading the most of its trials.

      • Azidus Brasil18%
      • Berlin-Chemie AG Menarini Group18%

      Modalities

      Drugs on this target by ChEMBL molecule type.

      • Other13100%

      The Landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. 12 of 13 act as: Antithrombin-III activator; the rest name their own mechanism.
      HeparinApprovedDaiichi SankyoOligosaccharideActivator—253—
      Heparin sodiumApprovedAzidus BrasilOligosaccharideActivator—245—
      Heparin calciumApproved—OligosaccharideActivator—244—
      Enoxaparin sodiumApprovedSanofiOligosaccharideActivator—61Boxed warning
      Dalteparin sodiumApprovedPfizerOligosaccharideActivator—21Boxed warning
      Tinzaparin sodiumApprovedLEO PharmaOligosaccharideActivator—21—
      FondaparinuxApprovedViatrisOligosaccharideActivator—5Boxed warning
      Nadroparin calciumApprovedItalfarmacoOligosaccharideActivator—3—
      Ardeparin sodiumApprovedPfizerOligosaccharideActivator—0—
      Danaparoid sodiumApprovedAspen GlobalOtherActivator—0—
      Bemiparin sodiumPhase 3Berlin-Chemie AG Menarini GroupOligosaccharideActivator—20—
      Parnaparin sodiumPhase 3—OligosaccharideActivator—0—
      Semuloparin sodiumPhase 3SanofiOligosaccharideInhibitorAntithrombin-III inhibitor0—

      Open Trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 37 in all, from ClinicalTrials.gov.
      Prophylactic Strategies for Mitigating Central Nervous System Relapse in Diffuse Large B-Cell LymphomaHeparin, Heparin calcium, Heparin sodiumPhase 2Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences2026-11-04
      Reduced-Dose Thrombolysis in Intermediate-Risk Pulmonary Embolism With High-Risk FeaturesHeparin, Heparin calcium, Heparin sodiumPhase 3Not yet recruitingChina National Center for Cardiovascular Diseases2026-11-04
      Effect of LMWH on Neonatal Outcomes in Isolated OligohydramniosEnoxaparin sodium, Heparin, Heparin calcium, Heparin sodiumPhase 4RecruitingPAEC General Hospital, Islamabad2026-10-30
      Danang Cerebral Venous Thrombosis RegistryHeparin, Heparin calcium, Heparin sodium—RecruitingDa Nang Hospital2026-10-22
      Post Pulmonary Embolism In Patients Treated With Catheter Based TherapyHeparin, Heparin calcium, Heparin sodiumNot applicableNot yet recruitingAssiut University2026-10-21
      Comparison of DOACs and LMWH for Thromboprophylaxis After Total Knee ArthroplastyEnoxaparin sodium, Heparin, Heparin calcium, Heparin sodiumNot applicableRecruitingMilitary Hospital of Tunis2026-10-09
      Fasciotomy and Predilation for Radial Artery Grafts in CABGHeparin, Heparin calcium, Heparin sodiumNot applicableRecruitingRuijin Hospital2026-10-09
      TRiP-cast Score Validation and Evaluation of Adherence to Preventive Anticoagulant Treatment in Patients With Lower Limb Trauma Requiring ImmobilizationHeparin, Heparin calcium, Heparin sodium—RecruitingUniversity of Monastir2026-10-07
      Rivaroxaban vs Enoxaparin After Cesarean Section: Laboratory Thromboprophylaxis OutcomesEnoxaparin sodiumNot applicableRecruitingWolfson Medical Center2026-09-15
      Randomized Assessor-Masked Trial of Moderate Graduated Compression Stockings for Popliteal Vein Dilation During Long-Haul Economy-Class Air Travel After Aesthetic SurgeryEnoxaparin sodiumNot applicableRecruitingResearch Inc2026-09-09
      Efficacy of Progesterone and Low Molecular Weight Heparin in Recurrent Pregnancy LossEnoxaparin sodiumPhase 3Not yet recruitingGeneral University Hospital, Prague2026-09-01
      Comparison of Visual Outcomes of Pars Plana Vitrectomy With and Without Injection Clexane for Rhegmatogenous Retinal Detachment Proliferative VitreoretinopathyEnoxaparin sodiumNot applicableActive, not recruitingLahore General Hospital2026-08-26
      Apixaban Versus Enoxaparin for Postpartum Venous Thromboembolism ProphylaxisEnoxaparin sodiumNot applicableNot yet recruitingRon Beloosesky MD2026-07-21
      Extended Prophylactic Anticoagulation Following Spinal Surgery for Metastatic DiseaseEnoxaparin sodiumPhase 4Not yet recruitingJames Bayley2026-07-20
      Optimizing Anticoagulation in Pregnancies With Mechanical Heart ValvesDalteparin sodiumNot applicableRecruitingMount Sinai Hospital, Canada2026-06-22
      Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant ImmunochemotherapyBemiparin sodiumPhase 3RecruitingHenan Cancer Hospital2026-06-05
      The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Dalteparin sodium, Tinzaparin sodiumNot applicableNot yet recruitingUniversity College Dublin2026-04-30
      Study to Determine the Comparative Pharmacodynamics of Enoxaparin Sodium Biosimilar With That From ClexaneDalteparin sodium, Tinzaparin sodiumPhase 1Not yet recruitingEgyptian International Pharmaceutical Industries Co2026-04-08
      Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell CarcinomaBemiparin sodiumPhase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2026-04-01
      Effect of Anticoagulant Therapy on Endometrial Receptivity and Pregnancy Outcomes in InfertilityDalteparin sodium, Tinzaparin sodium—RecruitingTang-Du Hospital2026-03-27
      Evaluating Health Literacy, Expectations and Regrets in Patients Undergoing Major Abdominal Surgery for Malignant DiseaseBemiparin sodium—RecruitingCopenhagen University Hospital, Rigshospitalet2026-03-05
      Totally Versus Hybrid Minimally Invasive Esophagectomy for Esophageal CancerBemiparin sodiumNot applicableNot yet recruitingUniversity Hospital, Lille2026-02-13
      LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionTinzaparin sodiumPhase 4RecruitingAlexandra Hospital, Athens, Greece2026-01-23
      Balloon Dilation in Patients Undergoing Minimally Invasive Ivor Lewis Esophagectomy and Its Effect on Reducing DGCEBemiparin sodiumNot applicableRecruitingUniversity Hospital, Basel, Switzerland2026-01-21
      Neoadjuvant Immunotherapy Combined With Chemotherapy Sequenced With Endoscopic Resection for Esophageal Cancer (Endosurgery-02)Bemiparin sodiumPhase 1RecruitingShanghai Zhongshan Hospital2026-01-05
      Intravenous Immunoglobulin for the Treatment of Acute Exacerbations of Idiopathic Pulmonary FibrosisFondaparinuxPhase 3RecruitingArgyrios Tzouvelekis2025-12-23
      Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic MalignanciesDalteparin sodium, Tinzaparin sodiumNot applicableRecruitingMedical University of Gdansk2025-12-08
      Neoadjuvant Ivonescimab(AK112) Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell CarcinomaBemiparin sodiumPhase 2RecruitingSecond Affiliated Hospital, Zhejiang University, School of Medicine2025-11-24
      Hip Fracture Surgery Arterial and Venous Thrombotic Events PreventionDalteparin sodium, Fondaparinux, Tinzaparin sodiumPhase 3Not yet recruitingMcMaster University2025-11-14
      Short-term Low-dose Low-molecular-weight Heparin to Prevent Postpartum ThrombosisDalteparin sodium, Tinzaparin sodium, Nadroparin calciumPhase 3RecruitingMarc Blondon2025-08-24
      Edoxaban Steady-State PK/PD in Adults With Nephrotic SyndromeDalteparin sodium, Tinzaparin sodiumNot applicableNot yet recruitingPeking University People's Hospital2025-08-11
      NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCCBemiparin sodiumNot applicableActive, not recruitingRenJi Hospital2025-01-07
      Treatment With Aspirin Alone Versus Aspirin in Combination With Fondaparinux Before Early Coronary Assessment in Patients With Non-ST-Elevation Myocardial InfarctionFondaparinuxPhase 4RecruitingUniversity of Aarhus2024-11-29
      The PARTUM Trial: Postpartum Aspirin to Reduce Thromboembolism Undue MorbidityNadroparin calciumPhase 3RecruitingUniversity of Calgary2024-07-10
      Thromboprophylaxis in Lower Limb ImmobilisationFondaparinuxPhase 3RecruitingQueen Mary University of London2024-04-17
      Improving Outcome in Subarachnoid Hemorrhage wIth NadroparineNadroparin calciumPhase 2RecruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)2020-08-11
      START-Register: Survey on Anticoagulated Patients RegisterFondaparinux—RecruitingGUALTIERO PALARETI2014-08-19

      Diseases Most Associated With It

      Open Targets association score, 0 to 1; all associations
      Hereditary antithrombin deficiency
      0.85
      Deep vein thrombosis
      0.66
      Blood coagulation disease
      0.65
      Recurrent thrombophlebitis
      0.56
      Angina unstable
      0.54
      Hematologic disorder
      0.44

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL1950, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-18. Gene name, function (UniProt P01008, CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets

      Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.